Cellectis
CLLS
66 hedge funds and large institutions have $133M invested in Cellectis in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 6 closing their positions.
33,600% more call options, than puts
Call options by funds: $337K | Put options by funds: $1K
150% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 6
17% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 18
10% more funds holding
Funds holding: 60 → 66 (+6)
2.88% more ownership
Funds ownership: 31.15% → 34.03% (+2.9%)
41% less capital invested
Capital invested by funds: $226M → $133M (-$92.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CII
Capital International Inc
Los Angeles,
California
|
+$14.7M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$5.81M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$3.81M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$3.07M |
| 5 |
IG
ING Group
Amsterdam,
Netherlands
|
+$2.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.62M |
| 3 |
Millennium Management
New York
|
-$1.13M |
| 4 |
D.E. Shaw & Co
New York
|
-$1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$731K |
CLLS Hedge Fund Activity: Q1 2020 in Review
66 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2020, worth a combined $133M — down 41% from $226M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new CLLS positions and 6 closed out — a net gain of 9 holders — while 21 added to existing stakes and 18 trimmed.
The largest buyer was Capital International Inc, opening a new position worth an estimated $14.7M. The largest seller was Fidelity Investments, cutting an estimated $11.5M.
- 66 institutional investors held Cellectis (CLLS) as of Q1 2020, up from 60 in Q4 2019.
- Funds reported $133M of Cellectis stock for Q1 2020, down 41% quarter-over-quarter.
- 15 funds opened new Cellectis positions in Q1 2020 and 6 closed out, a net change of +9 holders.
- The largest Cellectis buyer in Q1 2020 was Capital International Inc, an estimated $14.7M added.
- The largest Cellectis seller in Q1 2020 was Fidelity Investments, an estimated $11.5M sold.
Based on aggregated 13F filings for Q1 2020.